Pegaptanib sodium (Synonyms: EYE001; NX1838) |
Catalog No.GC64346 |
Pegaptanib sodium is an RNA aptamer directed against vascular endothelial growth factor (VEGF)-165.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 222716-86-1
Sample solution is provided at 25 µL, 10mM.
Pegaptanib sodium is an RNA aptamer directed against vascular endothelial growth factor (VEGF)-165. Pegaptanib could be used for the study of neovascular age-related macular degeneration (AMD) [1].
Pegaptanib also inhibits VEGF165-mediated phosphorylation of VEGFR2 and phospholipase Cγ and inhibited VEGF165-induced calcium mobilization in human umbilical vein endothelial cells[1].
[1]. Eugene W M Ng, et al. Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease. Nat Rev Drug Discov. 2006 Feb;5(2):123-32.
Average Rating: 5
(Based on Reviews and 9 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *